Advertisement

Zegerid OTC | Zegerid OTC

03:39 EDT 20th May 2013 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Drug Facts

Active ingredients (in each capsule) Purpose
Omeprazole 20 mg Acid reducer
Sodium Bicarbonate 1100 mg Allows absorption of this omeprazole product

Do not use if you are allergic to omeprazole

Do not use if you have:

These may be the signs of a serious condition. See your doctor.

Ask a doctor or pharmacist before use if you are taking

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Heartburn in children may sometimes be caused by a serious condition.

croscarmellose sodium, FD&C blue No. 1, gelatin, magnesium stearate, pharmaceutical ink, polysorbate 80, titanium dioxide

Call 1-888-ZEG-OTC (1-888-493-4682) between 8:00AM and 5:00PM Central Standard Time, Monday through Friday or visit www.ZegeridOTC.com

© Copyright & Distributed by MSD Consumer Care, Inc., PO Box 377, Memphis, TN 38151 USA, a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ USA.

NDC 11523-7265-3

Treats Frequent Heartburn

ZegeridOTC®

42CAPSULES

Three 14-Day Courses of Treatment

IMAGE zegerid-01.jpg

Manufacturer

MSD Consumer Care, Inc.

Active Ingredients

Source

Drugs and Medications [ 2 Associated Drugs and Medications listed on BioPortfolio]

Zegerid [Santarus, Inc.]

These highlights do not include all the information needed to use ZEGERID safely and effectively. See full prescribing information for ZEGERID. ZEGERID (omeprazole/sodium bicarbonate) Powder for Oral...

Zegerid® with magnesium hydroxide (omeprazole/sodium bicarbonate/magnesium hydroxide) [Santarus, Inc.]

ZEGERID® with Magnesium Hydroxide (omeprazole/sodium bicarbonate/magnesium hydroxide)

Clinical Trials [ 6 Associated Clinical Trials listed on BioPortfolio]

Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study

Compare the percent of subjects with moderate/severe esophagitis who achieve complete endoscopic resolution after 8 weeks of treatment morning vs. bedtime.

Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid Suppression

The purpose of this study is to compare Prilosec OTC® and Zegerid® in their effects on gastric acid suppression.

Ulcer Prevention Study in Post Gastric Bypass Patients

This research is to determine which medication, Zegerid (Omeprazole/Sodium Bicarbonate) or Pepcid AC (Famotidine), works best at reducing the chance that a patient will get an ulcer after...

Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(COMPLETED)

This study will determine differences between PPI formulations relative to their effects on gastric acidity

A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (Study CL2008-02)(COMPLETED)

Open-label randomized crossover design study. 60 participants will be evaluated on Day 1 to compare effects on stomach acid; 30 participants will continue treatment for 7 days and will hav...

PubMed Articles [0 Results]

None

Search BioPortfolio:
Advertisement

Drugs and Medication Quicklinks


Searches Linking to this Drug Record

Advertisement